相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiac ryanodine receptor calcium release deficiency syndrome
Bo Sun et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Interplay between Triadin and Calsequestrin in the Pathogenesis of CPVT in the Mouse
Marine Cacheux et al.
MOLECULAR THERAPY (2020)
50 Years of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) - Time to Explore the Dark Side of the Moon
Andreas Pflaumer et al.
HEART LUNG AND CIRCULATION (2020)
The arrhythmogenic N53I variant subtly changes the structure and dynamics in the calmodulin N-terminal domain, altering its interaction with the cardiac ryanodine receptor
Christian Holt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Classification and correlation of RYR2 missense variants in individuals with catecholaminergic polymorphic ventricular tachycardia reveals phenotypic relationships
Damilola Olubando et al.
JOURNAL OF HUMAN GENETICS (2020)
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1
Andrea Mazzanti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms ofCASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia
Kevin Ng et al.
CIRCULATION (2020)
Stabilizer Cell Gene Therapy A Less-Is-More Strategy to Prevent Cardiac Arrhythmias
Michael B. Liu et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)
Unnatural verticilide enantiomer inhibits type 2 ryanodine receptor-mediated calcium leak and is antiarrhythmic
Suzanne M. Batiste et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca2+/Calmodulin-Dependent Kinase II
Vassilios J. Bezzerides et al.
CIRCULATION (2019)
Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry
Lia Crotti et al.
EUROPEAN HEART JOURNAL (2019)
International Triadin Knockout Syndrome Registry The Clinical Phenotype and Treatment Outcomes of Patients With Triadin Knockout Syndrome
Daniel J. Clemens et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2019)
Ryanodine receptor-bound calmodulin is essential to protect against catecholaminergic polymorphic ventricular tachycardia
Yoshihide Nakamura et al.
JCI INSIGHT (2019)
Structural Immaturity of Human iPSC-Derived Cardiomyocytes: In Silico Investigation of Effects on Function and Disease Modeling
Jussi T. Koivumaki et al.
FRONTIERS IN PHYSIOLOGY (2018)
In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia
Xiaolu Pan et al.
CIRCULATION RESEARCH (2018)
Viral delivered gene therapy to treat catecholaminergic polymorphic ventricular tachycardia (CPVT2) in mouse models
Efrat Kurtzwald-Josefson et al.
HEART RHYTHM (2017)
A cryo-EM-based model of phosphorylation- and FKBP12.6-mediated allosterism of the cardiac ryanodine receptor
Sonali Dhindwal et al.
SCIENCE SIGNALING (2017)
A cryo-EM-based model of phosphorylation- and FKBP12.6-mediated allosterism of the cardiac ryanodine receptor
Sonali Dhindwal et al.
SCIENCE SIGNALING (2017)
The Hope and Hype of CRISPR-Cas9 Genome Editing A Review
Kiran Musunuru
JAMA CARDIOLOGY (2017)
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2)
Rossana Bongianino et al.
CIRCULATION RESEARCH (2017)
Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and Sparks
Nieves Gomez-Hurtado et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2016)
TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT
Harsha D. Devalla et al.
EMBO MOLECULAR MEDICINE (2016)
Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia
Ida S. Leren et al.
HEART RHYTHM (2016)
Diagnostic Approach to Unexplained Cardiac Arrest (from the FIVI-Gen Study)
Juan Jimenez-Jaimez et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Ablation of HRC alleviates cardiac arrhythmia and improves abnormal Ca handling in CASQ2 knockout mice prone to CPVT
Bin Liu et al.
CARDIOVASCULAR RESEARCH (2015)
The Mechanism of Flecainide Action in CPVT Does Not Involve a Direct Effect on RyR2
Mark L. Bannister et al.
CIRCULATION RESEARCH (2015)
Catecholaminergic Polymorphic Ventricular Tachycardia in Children Analysis of Therapeutic Strategies and Outcomes From an International Multicenter Registry
Thomas M. Roston et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2015)
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)
Silvia G. Priori et al.
EUROPEAN HEART JOURNAL (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Gene therapy to treat cardiac arrhythmias
Rossana Bongianino et al.
NATURE REVIEWS CARDIOLOGY (2015)
Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function
Yan-Ting Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Single Delivery of an Adeno-Associated Viral Construct to Transfer the CASQ2 Gene to Knock-In Mice Affected by Catecholaminergic Polymorphic Ventricular Tachycardia Is Able to Cure the Disease From Birth to Advanced Age
Marco Denegri et al.
CIRCULATION (2014)
Divergent Regulation of Ryanodine Receptor 2 Calcium Release Channels by Arrhythmogenic Human Calmodulin Missense Mutants
Hyun Seok Hwang et al.
CIRCULATION RESEARCH (2014)
Triadin regulates cardiac muscle couplon structure and microdomain Ca2+ signalling: a path towards ventricular arrhythmias
Nagesh Chopra et al.
CARDIOVASCULAR RESEARCH (2013)
Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia
Nian Liu et al.
CIRCULATION RESEARCH (2013)
Efficacy of Implantable Cardioverter Defibrillators in Young Patients With Catecholaminergic Polymorphic Ventricular Tachycardia: Success Depends on Substrate
Christina Y. Miyake et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2013)
Genome Engineering of Drosophila with the CRISPR RNA-Guided Cas9 Nuclease
Scott J. Gratz et al.
GENETICS (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia
E. Di Pasquale et al.
CELL DEATH & DISEASE (2013)
Importance of Ventricular Tachycardia Storms Not Terminated by Implantable Cardioverter Defibrillators Shocks in Patients With CASQ2 Associated Catecholaminergic Polymorphic Ventricular Tachycardia
Ibrahim Marai et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Mutations in Calmodulin Cause Ventricular Tachycardia and Sudden Cardiac Death
Mette Nyegaard et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Viral Gene Transfer Rescues Arrhythmogenic Phenotype and Ultrastructural Abnormalities in Adult Calsequestrin-Null Mice With Inherited Arrhythmias
Marco Denegri et al.
CIRCULATION RESEARCH (2012)
CaMKII binding to GluN2B is critical during memory consolidation
Amy R. Halt et al.
EMBO JOURNAL (2012)
The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands
Miyuki Hayashi et al.
EUROPACE (2012)
Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human
Nathalie Roux-Buisson et al.
HUMAN MOLECULAR GENETICS (2012)
Calsequestrin 2 deletion shortens the refractoriness of Ca2+ release and reduces rate-dependent Ca2+-alternans in intact mouse hearts
Dmytro Kornyeyev et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Targeting intracellular calcium cycling in catecholaminergic polymorphic ventricular tachycardia: a theoretical investigation
Ruey J. Sung et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Inherited Dysfunction of Sarcoplasmic Reticulum Ca2+ Handling and Arrhythmogenesis
Silvia G. Priori et al.
CIRCULATION RESEARCH (2011)
Short Communication: Flecainide Exerts an Antiarrhythmic Effect in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia by Increasing the Threshold for Triggered Activity
Nian Liu et al.
CIRCULATION RESEARCH (2011)
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
Michael J. Ackerman et al.
EUROPACE (2011)
Bidirectional ventricular tachycardia: Ping pong in the His-Purkinje system
Alex A. Baher et al.
HEART RHYTHM (2011)
Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia
Raymond W. Sy et al.
HEART RHYTHM (2011)
Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia
Nian Liu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
So Little Source, So Much Sink: Requirements for Afterdepolarizations to Propagate in Tissue
Yuanfang Xie et al.
BIOPHYSICAL JOURNAL (2010)
Dantrolene, a Therapeutic Agent for Malignant Hyperthermia, Inhibits Catecholaminergic Polymorphic Ventricular Tachycardia in a RyR2R2474S/+ Knock-In Mouse Model
Shigeki Kobayashi et al.
CIRCULATION JOURNAL (2010)
Catecholaminergic Polymorphic Ventricular Tachycardia Is Caused by Mutation-Linked Defective Conformational Regulation of the Ryanodine Receptor
Hitoshi Uchinoumi et al.
CIRCULATION RESEARCH (2010)
Rough endoplasmic reticulum to junctional sarcoplasmic reticulum trafficking of calsequestrin in adult cardiomyocytes
Timothy P. McFarland et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia
Meiso Hayashi et al.
CIRCULATION (2009)
Calsequestrin isoforms localize to different ER subcompartments: Evidence for polymer and heteropolymer-dependent localization
Michelle L. Milstein et al.
EXPERIMENTAL CELL RESEARCH (2009)
Store overload-induced Ca2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes
David H. MacLennan et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
Hiroshi Watanabe et al.
NATURE MEDICINE (2009)
Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias
Nagesh Chopra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Gatecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin
Giorgia Valle et al.
BIOCHEMICAL JOURNAL (2008)
Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin - A complex arrhythmogenic cascade in a knock in mouse model
Nicoletta Rizzi et al.
CIRCULATION RESEARCH (2008)
Disruption of calcium homeostasis and arrhythmogenesis induced by mutations in the cardiac ryanodine receptor and calsequestrin
Nian Liu et al.
CARDIOVASCULAR RESEARCH (2008)
Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death
Dawei Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia
Marina Cerrone et al.
CIRCULATION RESEARCH (2007)
Characterization of human cardiac calsequestrin and its deleterious mutants
EunJung Kim et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Functional consequence of protein kinase A-dependent phosphorylation of the cardiac ryanodine receptor -: Sensitization of store overload-induced Ca2+ release
Bailong Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia
Lei Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves - Threshold sarcoplasmic reticulum calcium content is required
Luigi A. Venetucci et al.
CIRCULATION RESEARCH (2007)
Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia
Uwais Mohamed et al.
HEART RHYTHM (2006)
Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy
Prince J. Kannankeril et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia - Insights from a RyR2 R4496C knock-in mouse model
Nian Liu et al.
CIRCULATION RESEARCH (2006)
Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death
Dmitry Terentyev et al.
CIRCULATION RESEARCH (2006)
Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure
X Ai et al.
CIRCULATION RESEARCH (2005)
Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death
DW Jiang et al.
CIRCULATION RESEARCH (2005)
Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor
M Cerrone et al.
CIRCULATION RESEARCH (2005)
Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2
XHT Wehrens et al.
SCIENCE (2004)
RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR)
DW Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores:: Mechanism for hereditary arrhythmia
D Terentyev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death
XHT Wehrens et al.
CELL (2003)
Molecular basis of calmodulin binding to cardiac muscle Ca2+ release channel (ryanodine receptor)
N Yamaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Regulation of calcium release by interdomain interaction within ryanodine receptors
N Ikemoto et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2002)
A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel
H Lahat et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts
SO Marx et al.
CELL (2000)
分享论文
